• Thumbnail for Convidecia
    AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino...
    37 KB (3,397 words) - 07:19, 24 September 2024
  • Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • Thumbnail for COVID-19 pandemic
    US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
    369 KB (32,740 words) - 18:58, 9 November 2024
  • vaccines were two-dose vaccines, with the exception single-dose vaccines Convidecia and the Janssen COVID‑19 vaccine, and vaccines with three-dose schedules...
    202 KB (23,026 words) - 19:12, 2 November 2024
  • Thumbnail for COVID-19
    vaccines were two-dose vaccines, with the exception single-dose vaccines Convidecia and the Janssen COVID‑19 vaccine, and vaccines with three-dose schedules...
    288 KB (33,185 words) - 16:47, 7 November 2024
  • Thumbnail for Timeline of the COVID-19 pandemic
    US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
    21 KB (763 words) - 21:39, 16 October 2024
  • Thumbnail for COVID-19 pandemic deaths
    US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
    18 KB (1,606 words) - 21:29, 2 November 2024
  • Thumbnail for COVID-19 lockdowns
    US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
    72 KB (15,197 words) - 22:02, 12 September 2024
  • Thumbnail for CanSino Biologics
    later worked together to develop an Ebola vaccine. AD5-nCOV, trade-named Convidecia, is a single-dose viral vector COVID-19 vaccine developed by CanSino....
    15 KB (1,099 words) - 19:03, 12 September 2024
  • Thumbnail for Responses to the COVID-19 pandemic in September 2022
    Products Administration granted approval for the Convidecia Air, an inhaled version of the Convidecia vaccine, to be used as a booster dose. China - In...
    8 KB (636 words) - 23:00, 28 August 2024